Publication | Closed Access
Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells
30
Citations
23
References
2019
Year
Molecular PharmacologyPharmacological EfficacyOncogenic AgentMedicineAryl Hydrocarbon ReceptorBreast CancerCancer BiologyAnti-cancer AgentPharmacologyRadiation OncologyTumor BiologyEnhanced Akr1c3 Expression
| Year | Citations | |
|---|---|---|
Page 1
Page 1